Torno Capital, LLC Summit Therapeutics Inc. Transaction History

Torno Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$16.65 - $23.76 $138,328 - $197,398	-8,308 Closed	0 $0
Q4 2024 May 14, 2025	BUY	$17.52 - $23.46 $81,800 - $109,534	4,669 Added 128.3%	8,308 $148 Million
Q4 2024 Feb 14, 2025	BUY	$17.52 - $23.46 $81,800 - $109,534	4,669 Added 128.3%	8,308 $148 Million
Q3 2024 May 14, 2025	SELL	$6.89 - $31.93 $32,169 - $149,081	-4,669 Reduced 56.2%	3,639 $79.7 Million
Q3 2024 Nov 13, 2024	BUY	$6.89 - $31.93 $25,072 - $116,193	3,639 New	3,639 $79.7 Million

267

94.2M

4.72M

4.03M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.67B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Torno Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Torno Capital, LLC with notifications on news.